From design to delivery: SA25 aseptic filling workcell

What does it take for a growing biotech organization to modernize its approach to aseptic filling?

At INITS, we set out to strengthen our clinical manufacturing capabilities with a safer, more flexible system for small‑batch GMP production. We chose the SA25 gloveless robotic isolator to help reduce human intervention and support multiple formats as the needs evolve.

Our new video follows that story from the moment the system takes shape at our Burnaby site to the day it arrives in France for installation at INITS. Along the way, you’ll see how more than 4,000 components are assembled, tested, and refined through standardized processes designed to support sterility, repeatability, and efficient changeovers.

It’s a look at how INITS is preparing for the future – and how thoughtful technology choices can help move new therapies toward the clinic with greater confidence.

What does it take for a growing biotech organization to modernize its approach to aseptic filling?

At INITS, we set out to strengthen our clinical manufacturing capabilities with a safer, more flexible system for small‑batch GMP production. We chose the SA25 gloveless robotic isolator to help reduce human intervention and support multiple formats as the needs evolve.

Our new video follows that story from the moment the system takes shape at our Burnaby site to the day it arrives in France for installation at INITS. Along the way, you’ll see how more than 4,000 components are assembled, tested, and refined through standardized processes designed to support sterility, repeatability, and efficient changeovers.

It’s a look at how INITS is preparing for the future – and how thoughtful technology choices can help move new therapies toward the clinic with greater confidence.

What does it take for a growing biotech organization to modernize its approach to aseptic filling?

At INITS, we set out to strengthen our clinical manufacturing capabilities with a safer, more flexible system for small‑batch GMP production. We chose the SA25 gloveless robotic isolator to help reduce human intervention and support multiple formats as the needs evolve.

Our new video follows that story from the moment the system takes shape at our Burnaby site to the day it arrives in France for installation at INITS. Along the way, you’ll see how more than 4,000 components are assembled, tested, and refined through standardized processes designed to support sterility, repeatability, and efficient changeovers.

It’s a look at how INITS is preparing for the future – and how thoughtful technology choices can help move new therapies toward the clinic with greater confidence.